Echocardiographic assessment of cardiac involvement in systemic al amyloidosis in relation to whole body amyloid load measured by serum amyloid p component (sap) clearance

American Journal of Cardiology

Volumn 80, Issue 8, 1997, Pages 1104-1108

  Clesham, Gerald J ^a,b   Vigushin, David M ^a   Hawkins, Philip N ^a   Pepys, Mark B ^a   Oakley, Celia M ^a   Nihoyannopoulos, Petros ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DRUG CLEARANCE; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VENTRICLES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; SERUM AMYLOID P-COMPONENT; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030671318     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00617-6     Document Type: Article

References (11)

1. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 1983;52:137-146.
2. 123I-labeled serum amyloid P component. N Eng J Med 1990;323:508-513.
3. Hawkins PN, Wootton R, Pepys MB. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest 1990;86:1862-1869.
4. Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, Offord KP, Greipp PR, Edwards WD, Tajik AJ. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardio 1985;6:737-743.
5. Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz RA, Tajik AJ. Doppler characterisation of left ventricular diasolic function in cardiac amyloidosis. J Am Coll Cardiol 1989;13:1017-1026.
6. Klein AL, Hatle LK, Taliercio CP, Oh JK, Kyle RA, Gertz MA et al. Prognostic significance of doppler measures of diastolic function in cardiac amyloidosis. Circulation 1991;83:808-816.
7. Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P component (SAP) by amyloid fibrils. Clin Exp Imnumol 1979;38:284-293.
8. Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targetting by circulating human serum amyloid P component. Lancet 1988;1:1413-1418.
9. Vigushin DM, Pepys MB, Hawkins PN. Comparison of histology with SAP scintigraphy for evaluation of amyloidosis. In Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and Amyloidosis 1993. Pearl River, New York: Parthenon Publishing, 1994:685-687.
10. Hosenpud JD, De Marco T, Frazier H, Griffith BP, Uretsky BF, Menkis AH, O'Connell JB, Olivari MT, Valantine HA. Progression of systemic disease and reduced long term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 1991;84(supp III):III338-343.
11. Hall R, Hawkins PN. Cardiac transplantation for AL amyloidosis. Br Med J 1994;309:1135-1137.